Skip to content
10-K

Annual Report

ANGIOGENEX, INC.

0001469709-19-000043

← back to feed
Filed
Mar 28, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 27, 2019 30.39M sh
Operating Cash Flow FY 2018 · Dec 31, 2018 −$453.79K
Operating Cash Flow FY 2018 · Dec 31, 2017 −$528.8K
Stockholders Equity FY 2018 · Dec 31, 2018 −$1.07M
Stockholders Equity FY 2018 · Dec 31, 2017 −$654.52K
Stockholders Equity FY 2018 · Dec 31, 2016 −$750.81K
Current Liabilities FY 2018 · Dec 31, 2018 $1.1M
Current Liabilities FY 2018 · Dec 31, 2017 $1.14M
Total Liabilities FY 2018 · Dec 31, 2018 $1.12M
Total Liabilities FY 2018 · Dec 31, 2017 $1.17M
Current Assets FY 2018 · Dec 31, 2018 $52.82K
Current Assets FY 2018 · Dec 31, 2017 $515.31K
Total Assets FY 2018 · Dec 31, 2018 $52.82K
Total Assets FY 2018 · Dec 31, 2017 $515.31K
Sga Expense FY 2018 · Dec 31, 2018 $406.92K
Sga Expense FY 2018 · Dec 31, 2017 $354.85K
Rd Expense FY 2018 · Dec 31, 2018 $30.74K
Rd Expense FY 2018 · Dec 31, 2017 $291.34K
Net Income FY 2018 · Dec 31, 2018 −$435.45K
Net Income FY 2018 · Dec 31, 2017 −$683.03K
Operating Income FY 2018 · Dec 31, 2018 −$437.66K
Operating Income FY 2018 · Dec 31, 2017 −$646.19K